Bicluster Expression of Patient Tumors
Expression of genes from patient tumors in bicluster on left side of red dashed line and out of bicluster on right of red dashed line. Each patient tumor is represented as a boxplot, ordered by their median expression for the bicluster genes (smallest to largest) and colored according to it's GBM subtype. |
Enrichment of Tumor Subtypes in Qunitiles
Patient tumors are sorted as on the left and broken into quintiles following the dashed grey lines. Then each quintile is tested for enrichment of each tumor subtype. The deviation from zero indicate -log10(enrichment p-value), and positive values indicate over-enrichment and negative values underenrichment. |
Genes | Patient Tumors | FPC Var. Exp. (Perm. p-value) | Survival (p-value) | Independent Replication |
---|---|---|---|---|
34 | 408 | 0.48 (0.0E+00) |
2.69 (7.2E-03) |
Co-expression Survival |
Regulators | Causal Flows | Enriched GO BPs | Enriched Hallmarks of Cancer |
---|---|---|---|
1 | 1 | 38 | 0 |
Study | FPC Var. Exp. (Perm. p-value) | Survival (p-value) |
---|---|---|
Gravendeel, et al. 2009 | 0.46 (0.0E+00) | 2.83 (4.6E-03) |
Madhavan, et al. 2009 | 0.47 (0.0E+00) | 4.21 (2.6E-05) |
Murat, et al. 2008 | 0.37 (0.0E+00) | -0.77 (4.4E-01) |
Type | Name | Action | Prior Knowledge |
---|---|---|---|
TF | RELB | Activator | Yes |
Mutation | Regulator | Bicluster | ||
---|---|---|---|---|
A6B1_AND_A6B4_INTEGRIN_SIGNALING | RELB | TARGETSCAN_241 |
GO Term | GO BP ID | Genes |
Regulation of complement activation, lectin pathway | GO:0001868 | |
Negative regulation of complement activation, lectin pathway | GO:0001869 | A2M SERPING1 |
Response to molecule of bacterial origin | GO:0002237 | CXCL2 |
Immune system process | GO:0002376 | SQSTM1 |
Acute inflammatory response | GO:0002526 | ALOX5 |
Regulation of acute inflammatory response | GO:0002673 | |
Regulation of immune system process | GO:0002682 | |
Positive regulation of immune system process | GO:0002684 | |
Negative regulation of humoral immune response | GO:0002921 | |
Response to stress | GO:0006950 | GADD45B SQSTM1 |
Defense response | GO:0006952 | |
Inflammatory response | GO:0006954 | C5AR1 CCL2 CCL7 CSF1 CXCL2 FOS RELB |
Immune response | GO:0006955 | C5AR1 CXCL2 OSM |
Complement activation | GO:0006956 | C1S |
Humoral immune response | GO:0006959 | CCL2 |
Intracellular protein kinase cascade | GO:0007243 | |
Response to temperature stimulus | GO:0009266 | |
Response to radiation | GO:0009314 | JUNB PLK3 |
Response to external stimulus | GO:0009605 | |
Response to wounding | GO:0009611 | CCL2 CTSB |
Response to abiotic stimulus | GO:0009628 | |
Regulation of metabolic process | GO:0019222 | |
Myeloid cell differentiation | GO:0030099 | |
Regulation of defense response | GO:0031347 | |
Regulation of response to external stimulus | GO:0032101 | |
Response to progesterone stimulus | GO:0032570 | CCL2 FOS JUNB |
Natural killer cell chemotaxis | GO:0035747 | |
Innate immune response | GO:0045087 | C1S CSF1 CTSB FOS NFKBIA RELB SERPING1 |
Negative regulation of complement activation | GO:0045916 | |
Positive regulation of biological process | GO:0048518 | |
Regulation of response to stimulus | GO:0048583 | |
Positive regulation of response to stimulus | GO:0048584 | |
Response to stimulus | GO:0050896 | |
Regulation of protein metabolic process | GO:0051246 | |
Response to camp | GO:0051591 | DUSP1 FOS JUNB |
Regulation of molecular function | GO:0065009 | |
Negative regulation of protein activation cascade | GO:2000258 | |
Regulation of natural killer cell chemotaxis | GO:2000501 |
|
Legend: Hanahan and Weinberg, Cell 2011 |